204 related articles for article (PubMed ID: 31035425)
21. Characterization of a novel α-conotoxin TxID from Conus textile that potently blocks rat α3β4 nicotinic acetylcholine receptors.
Luo S; Zhangsun D; Zhu X; Wu Y; Hu Y; Christensen S; Harvey PJ; Akcan M; Craik DJ; McIntosh JM
J Med Chem; 2013 Dec; 56(23):9655-63. PubMed ID: 24200193
[TBL] [Abstract][Full Text] [Related]
22. α-Conotoxins active at α3-containing nicotinic acetylcholine receptors and their molecular determinants for selective inhibition.
Cuny H; Yu R; Tae HS; Kompella SN; Adams DJ
Br J Pharmacol; 2018 Jun; 175(11):1855-1868. PubMed ID: 28477355
[TBL] [Abstract][Full Text] [Related]
23. α-Conotoxin TxID and [S9K]TxID, α3β4 nAChR Antagonists, Attenuate Expression and Reinstatement of Nicotine-Induced Conditioned Place Preference in Mice.
Li X; You S; Xiong J; Qiao Y; Yu J; Zhangsun D; Luo S
Mar Drugs; 2020 Dec; 18(12):. PubMed ID: 33339145
[TBL] [Abstract][Full Text] [Related]
24. Fluorescently Labeled α-Conotoxin TxID, a New Probe for α3β4 Neuronal Nicotinic Acetylcholine Receptors.
Huang M; Zhu X; Yang Y; Tan Y; Luo S; Zhangsun D
Mar Drugs; 2022 Aug; 20(8):. PubMed ID: 36005514
[TBL] [Abstract][Full Text] [Related]
25. Critical residue properties for potency and selectivity of α-Conotoxin RgIA towards α9α10 nicotinic acetylcholine receptors.
Huynh PN; Harvey PJ; Gajewiak J; Craik DJ; Michael McIntosh J
Biochem Pharmacol; 2020 Nov; 181():114124. PubMed ID: 32593612
[TBL] [Abstract][Full Text] [Related]
26. Nicotinic acetylcholine receptor subtype expression, function, and pharmacology: Therapeutic potential of α-conotoxins.
Tae HS; Adams DJ
Pharmacol Res; 2023 May; 191():106747. PubMed ID: 37001708
[TBL] [Abstract][Full Text] [Related]
27. Molecular interaction of α-conotoxin RgIA with the rat α9α10 nicotinic acetylcholine receptor.
Azam L; Papakyriakou A; Zouridakis M; Giastas P; Tzartos SJ; McIntosh JM
Mol Pharmacol; 2015 May; 87(5):855-64. PubMed ID: 25740413
[TBL] [Abstract][Full Text] [Related]
28. RegIIA: an α4/7-conotoxin from the venom of Conus regius that potently blocks α3β4 nAChRs.
Franco A; Kompella SN; Akondi KB; Melaun C; Daly NL; Luetje CW; Alewood PF; Craik DJ; Adams DJ; Marí F
Biochem Pharmacol; 2012 Feb; 83(3):419-26. PubMed ID: 22108175
[TBL] [Abstract][Full Text] [Related]
29. Loop2 Size Modification Reveals Significant Impacts on the Potency of α-Conotoxin TxID.
Dong J; Zhang P; Xie J; Xie T; Zhu X; Zhangsun D; Yu J; Luo S
Mar Drugs; 2023 May; 21(5):. PubMed ID: 37233480
[TBL] [Abstract][Full Text] [Related]
30. Structure-Activity Relationships of Alanine Scan Mutants αO-Conotoxins GeXIVA[1,2] and GeXIVA[1,4].
Xu P; Zhang P; Zhu X; Wu Y; Harvey PJ; Kaas Q; Zhangsun D; Craik DJ; Luo S
J Med Chem; 2023 Jul; 66(14):10092-10107. PubMed ID: 37464764
[TBL] [Abstract][Full Text] [Related]
31. α-Conotoxin Vc1.1 Structure-Activity Relationship at the Human α9α10 Nicotinic Acetylcholine Receptor Investigated by Minimal Side Chain Replacement.
Chu X; Tae HS; Xu Q; Jiang T; Adams DJ; Yu R
ACS Chem Neurosci; 2019 Oct; 10(10):4328-4336. PubMed ID: 31411453
[TBL] [Abstract][Full Text] [Related]
32. Alanine-Scanning Mutagenesis of α-Conotoxin GI Reveals the Residues Crucial for Activity at the Muscle Acetylcholine Receptor.
Ning J; Li R; Ren J; Zhangsun D; Zhu X; Wu Y; Luo S
Mar Drugs; 2018 Dec; 16(12):. PubMed ID: 30551685
[TBL] [Abstract][Full Text] [Related]
33. Discovery and Structural and Functional Characterization of a Novel A-Superfamily Conotoxin Targeting α9α10 Nicotinic Acetylcholine Receptor.
Huang Q; Chu X; Zhang H; Yu S; Zhang L; Zhang X; Yu R; Guo C; Dai Q
ACS Chem Biol; 2022 Sep; 17(9):2483-2494. PubMed ID: 36048451
[TBL] [Abstract][Full Text] [Related]
34. Molecular basis for the differential sensitivity of rat and human α9α10 nAChRs to α-conotoxin RgIA.
Azam L; McIntosh JM
J Neurochem; 2012 Sep; 122(6):1137-44. PubMed ID: 22774872
[TBL] [Abstract][Full Text] [Related]
35. Differential involvement of α4β2, α7 and α9α10 nicotinic acetylcholine receptors in B lymphocyte activation in vitro.
Koval L; Lykhmus O; Zhmak M; Khruschov A; Tsetlin V; Magrini E; Viola A; Chernyavsky A; Qian J; Grando S; Komisarenko S; Skok M
Int J Biochem Cell Biol; 2011 Apr; 43(4):516-24. PubMed ID: 21146628
[TBL] [Abstract][Full Text] [Related]
36. From Crystal Structures of RgIA4 in Complex with
Pan S; Fan Y; Zhu X; Xue Y; Luo S; Wang X
Mar Drugs; 2021 Dec; 19(12):. PubMed ID: 34940708
[TBL] [Abstract][Full Text] [Related]
37. Alpha-RgIA: a novel conotoxin that specifically and potently blocks the alpha9alpha10 nAChR.
Ellison M; Haberlandt C; Gomez-Casati ME; Watkins M; Elgoyhen AB; McIntosh JM; Olivera BM
Biochemistry; 2006 Feb; 45(5):1511-7. PubMed ID: 16445293
[TBL] [Abstract][Full Text] [Related]
38. Medicinal chemistry, pharmacology, and therapeutic potential of α-conotoxins antagonizing the α9α10 nicotinic acetylcholine receptor.
Li X; Tae HS; Chu Y; Jiang T; Adams DJ; Yu R
Pharmacol Ther; 2021 Jun; 222():107792. PubMed ID: 33309557
[TBL] [Abstract][Full Text] [Related]
39. Structural mechanisms for α-conotoxin activity at the human α3β4 nicotinic acetylcholine receptor.
Abraham N; Healy M; Ragnarsson L; Brust A; Alewood PF; Lewis RJ
Sci Rep; 2017 Mar; 7():45466. PubMed ID: 28361878
[TBL] [Abstract][Full Text] [Related]
40. Structural and Functional Characterization of a Novel α-Conotoxin Mr1.7 from Conus marmoreus Targeting Neuronal nAChR α3β2, α9α10 and α6/α3β2β3 Subtypes.
Wang S; Zhao C; Liu Z; Wang X; Liu N; Du W; Dai Q
Mar Drugs; 2015 May; 13(6):3259-75. PubMed ID: 26023835
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
